Bob
Senior Member
- Messages
- 16,455
- Location
- England (south coast)
Mark, you get the 'best post of the month' award, from me. Thank you so much for spelling out all of that with such clarity, while keeping a cool head (something i've not been able to do this week). I really appreciate the amount of thought, patience and effort that you put into it. You make a whole load of crucial points, and I agree with everything that you've said.
I'll just pick out one point to comment on for now... The following had crossed my mind as well... (my underlining)...
I didn't know that the paper had been edited down so much by the editors of Science (or i'd forgotten!)
I'll just pick out one point to comment on for now... The following had crossed my mind as well... (my underlining)...
- Indeed, since Ruscetti says that the failure to mention the 5AZA treatment of patient samples in Figure 2c was a trivial omission not necessary to the paper, and since Mikovits has asserted that the bulk of samples were treated exactly the same for patients and for controls, the most reasonable way to reconcile all these statements is that Figure 2c was included in the paper as the most clearly-defined image from their various experiments, because it best illustrated the contrast. That may seem a little misleading, but in the wider context of all the materials the researchers had at their disposal, and in the context of the review process re-editing the original paper down to a fraction of its original length, it seems to me most likely that they just presented the case in the strongest possible way by selecting the strongest image. If other slides which did not depend on the use of 5AZA, or where 5AZA was applied to both patient and control samples, showed similar contrasts, then this choice may not have been particularly misleading.
I didn't know that the paper had been edited down so much by the editors of Science (or i'd forgotten!)